Tag Archives: NASDAQ:QDEL

The President & CEO of Quidel (NASDAQ: QDEL) is Buying Shares

Yesterday, the President & CEO of Quidel (QDEL – Research Report), Douglas Bryant, bought shares of QDEL for $801.7K. Following Douglas Bryant’s last QDEL Buy transaction on November 03, 2015, the stock climbed by 137.7%. This recent transaction increases Douglas

A Director at Quidel (NASDAQ: QDEL) is Selling Shares

Yesterday, a Director at Quidel (QDEL – Research Report), Kenneth Buechler, sold shares of QDEL for $1M. Following Kenneth Buechler’s last QDEL Sell transaction on May 07, 2020, the stock climbed by 25.1%. In addition to Kenneth Buechler, one other

A Director at Quidel is Exercising Options

Yesterday it was reported that a Director at Quidel (QDEL – Research Report), Mary Lake Polan, exercised options to buy 9,041 QDEL shares at $21.07 a share, for a total transaction value of $190.5K. Following this transaction Mary Lake Polan’s

Quidel (QDEL) Gets a Buy Rating from Canaccord Genuity

Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Quidel (QDEL – Research Report) yesterday and set a price target of $75.00. The company’s shares closed last Monday at $64.19. According to TipRanks.com, Massaro is a top 100 analyst

Quidel Corp (QDEL) Initiated with a Buy at Canaccord Genuity

Quidel Corp (QDEL – Research Report) received a Buy rating and a $70 price target from Canaccord Genuity analyst Mark Massaro on June 26. The company’s shares closed on Friday at $59.32. According to TipRanks.com, Massaro is a top 100

Analysts Are Bullish on These Healthcare Stocks: Quidel Corp (QDEL), Biohaven Pharmaceutical Holding Co Ltd (BHVN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Quidel Corp (QDEL – Research Report) and Biohaven Pharmaceutical Holding Co Ltd (BHVN – Research Report) with bullish sentiments. Quidel Corp (QDEL)